JP Morgan Chase
CLBT icon

JP Morgan Chase’s Cellebrite CLBT Stock Holding History

JP Morgan Chase’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.89M Buy
596,600
+474,068
+387% +$7.14M ﹤0.01% 2897
2025
Q4 		$2.21M Sell
122,532
-561,310
-82% -$10.1M ﹤0.01% 3999
2025
Q3 		$12.7M Sell
683,842
-183,531
-21% -$2.88M ﹤0.01% 2514
2025
Q2 		$13.9M Buy
867,373
+300,046
+53% +$5.35M ﹤0.01% 2261
2025
Q1 		$11M Buy
567,327
+235,662
+71% +$4.96M ﹤0.01% 2452
2024
Q4 		$7.31M Sell
331,665
-95,990
-22% -$1.85M ﹤0.01% 3008
2024
Q3 		$7.2M Buy
427,655
+75,092
+21% +$1.11M ﹤0.01% 2910
2024
Q2 		$4.21M Buy
352,563
+120,519
+52% +$1.35M ﹤0.01% 3162
2024
Q1 		$2.57M Buy
232,044
+36,348
+19% +$371K ﹤0.01% 3639
2023
Q4 		$1.69M Buy
195,696
+73,957
+61% +$575K ﹤0.01% 3957
2023
Q3 		$931K Buy
121,739
+66,196
+119% +$497K ﹤0.01% 4110
2023
Q2 		$400K Sell
55,543
-28,470
-34% -$166K ﹤0.01% 4630
2023
Q1 		$512K Buy
84,013
+18,435
+28% +$99.9K ﹤0.01% 4485
2022
Q4 		$286K Buy
65,578
+9,162
+16% +$40.9K ﹤0.01% 4852
2022
Q3 		$221K Sell
56,416
-2,476
-4% -$12.4K ﹤0.01% 4901
2022
Q2 		$301K Buy
58,892
+9,393
+19% +$48.9K ﹤0.01% 4851
2022
Q1 		$317K Buy
49,499
+30,410
+159% +$202K ﹤0.01% 4950
2021
Q4 		$153K Buy
19,089
+5,664
+42% +$53.4K ﹤0.01% 5490
2021
Q3 		$124K Buy
+13,425
New +$140K ﹤0.01% 5464

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase's CLBT Position: Q1 2026 in Review

JP Morgan Chase increased its Cellebrite (CLBT) stake by 387% in Q1 2026, buying an estimated $7.14M and bringing the position to 596,600 shares worth $7.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2897.

JP Morgan Chase first reported a position in CLBT in Q3 2021 and has held it in 19 quarters since. The position peaked at $13.9M in Q2 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • JP Morgan Chase held 596,600 shares of Cellebrite worth $7.89M as of Q1 2026.
  • JP Morgan Chase bought 474,068 Cellebrite shares in Q1 2026, an estimated $7.14M.
  • Cellebrite made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2897 holding.
  • JP Morgan Chase first reported a position in Cellebrite in Q3 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's Cellebrite position peaked at $13.9M in Q2 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.